Effect of dexmedetomidine on etomidate-induced myoclonus: a randomized, double-blind controlled trial

References

• Song J-C, Lu Z-J, Jiao Y-F, et al. Etomidate anesthesia during ERCP caused more stable haemodynamic responses compared with propofol: a randomized clinical trial. Int J Med Sci. 2015;12:559–565. doi:10.7150/ijms.1152126180512
   PubMed Web of Science ®Google Scholar
• Morel J, Salard M, Castelain C, et al. Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. Br J Anaesth. 2011;107:503–509. doi:10.1093/bja/aer16921685487
   PubMed Web of Science ®Google Scholar
• Möller Petrun A, Kamenik M. Bispectral index-guided induction of general anaesthesia in patients undergoing major abdominal surgery using propofol or etomidate: a double-blind, randomized, clinical trial. Br J Anaesth. 2013;110:388–396. doi:10.1093/bja/aes41623166149
   PubMed Web of Science ®Google Scholar
• Nyman Y, von Hofsten K, Ritzmo C, Eksborg S, Lönnqvist PA. Effect of a small priming dose on myoclonic movements after intravenous anaesthesia induction with Etomidate-Lipuro in children. Br J Anaesth. 2011;107:225–228. doi:10.1093/bja/aer12921632605
   PubMed Web of Science ®Google Scholar
• Doenicke A, Roizen MF, Nebauer AE, Kugler A, Hoernecke R, Beger-Hintzen H. A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propyleneglycol. Anesth Analg. 1994;79:933–939.7978412
   PubMed Web of Science ®Google Scholar
• Komatsu R, You J, Mascha EJ, Sessler DI, Kasuya Y, Turan A. Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery. Anesth Analg. 2013;117(6):1329–1337. doi:10.1213/ANE.0b013e318299a51624257383
   PubMed Web of Science ®Google Scholar
• Isitemiz I, Uzman S, Toptaş M, et al. Prevention of etomidate-induced myoclonus: which is superior: fentanyl, midazolam, or a combination? A retrospective comparative study. Med Sci Monit. 2014;20:262–267. doi:10.12659/MSM.88983324535067
   PubMed Web of Science ®Google Scholar
• Hueter L, Schwarzkopf K, Simon M, Bredle D, Fritz H. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand. 2003;47:482–484.12694150
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yang Y, Zhou C, Bao Z. Using dezocine to prevent etomidate-induced myoclonus: a meta-analysis of randomized trials. Drug Des Devel Ther. 2017;11:2163–2170. doi:10.2147/DDDT.S137464
   PubMed Web of Science ®Google Scholar
• Gultop F, Akkaya T, Bedirli N, Gumus H. Lidocaine pretreatment reduces the frequency and severity of myoclonus induced by etomidate. J Anesth. 2010;24:300–302. doi:10.1007/s00540-010-0869-620108006
   PubMed Web of Science ®Google Scholar
• Zhou C, Zhu Y, Liu Z, Ruan L. Effect of pretreatment with midazolam on etomidate-induced myoclonus: a meta-analysis. J Int Med Res. 2017;45:399–406. doi:10.1177/030006051668288228415947
   PubMed Web of Science ®Google Scholar
• Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology. 1999;90:113–119. doi:10.1097/00000542-199901000-000179915320
   PubMed Web of Science ®Google Scholar
• Lv Z, Lu Z, Fang J, et al. Intravenous dezocine pretreatment reduces the incidence and intensity of myoclonus induced by etomidate. J Anesth. 2014;28:944–947. doi:10.1007/s00540-014-1842-624828848
   PubMed Web of Science ®Google Scholar
• He L, Ding Y, Chen H, Qian Y, Li Z. Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized, double-blinded controlled trial. J Anesth. 2015;29:143–145. doi:10.1007/s00540-014-1854-224858231
   PubMed Web of Science ®Google Scholar
• Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology. 1984;61:616–617. doi:10.1097/00000542-198411000-000296497005
   PubMed Web of Science ®Google Scholar
• Grant IS, Hutchison G. Epileptiform seizures during prolonged etomidate sedation. Lancet (Lond, Engl). 1983;2:511–512.
   PubMed Web of Science ®Google Scholar
• Voss LJ, Sleigh JW, Barnard JP, Kirsch HE. The howling cortex: seizures and general anesthetic drugs. Anesth Analg. 2008;107:1689–1703. doi:10.1213/ane.0b013e318185259518931234
   PubMed Web of Science ®Google Scholar
• Kugler J, Doenicke A, Laub M. The EEG after etomidate. Anaesthesiol Resusc. 1977;106:31–48.
   Google Scholar
• Mantz J, Josser J, Hamada S. Dexmedetomidine: new insights. Eur J Anaesthesiol. 2011;28:3–6. doi:10.1097/EJA.0b013e32833e266d20881501
   PubMed Web of Science ®Google Scholar
• Wagner DS, Brummet CM. Dexmedetomidine: as safe as safe can be. Semin Anesth Perioper Med Pain. 2006;25:77–83. doi:10.1053/j.sane.2006.02.003
   Google Scholar
• Luan HF, Zhao ZB, Feng JY, et al. Prevention of etomidate-induced myoclonus during anesthetic induction by pretreatment with dexmedetomidine. Braz J Med Biol Res. 2015;48:186–190. doi:10.1590/1414-431X2014410025351237
   PubMed Web of Science ®Google Scholar
• Mizrak A, Koruk S, Bilgi M, et al. Pretreatment with dexmedetomidine or thiopental decreases myoclonus after etomidate: a randomized, double-blind controlled trial. J Surg Res. 2010;159:e11–e16. doi:10.1016/j.jss.2009.07.03120018300
   PubMed Web of Science ®Google Scholar
• Dey S, Kumar M. Comparison of pretreatment with dexmedetomidine with midazolam for prevention of etomidate-induced myoclonus and attenuation of stress response at intubation: a randomized controlled study. J Anaesthesiol Clin Pharmacol. 2018;34(1):94–98. doi:10.4103/joacp.JOACP_297_1629643630
   PubMed Web of Science ®Google Scholar
• Du X, Zhou C, Pan L, Li C. Effect of dexmedetomidine in preventing etomidate-induced myoclonus: a meta-analysis. Drug Des Devel Ther. 2017;11:365–370. doi:10.2147/DDDT.S121979
   PubMed Web of Science ®Google Scholar